RNA Therapeutics Are Stepping Out of the Maze
| dc.contributor.author | Agrawal, Sudhir | |
| dc.date | 2022-08-11T08:09:57.000 | |
| dc.date.accessioned | 2022-08-23T16:50:05Z | |
| dc.date.available | 2022-08-23T16:50:05Z | |
| dc.date.issued | 2020-09-25 | |
| dc.date.submitted | 2020-11-02 | |
| dc.identifier.citation | <p>Agrawal S. RNA Therapeutics Are Stepping Out of the Maze. Trends Mol Med. 2020 Sep 25:S1471-4914(20)30212-4. doi: 10.1016/j.molmed.2020.08.007. Epub ahead of print. PMID: 32988738; PMCID: PMC7518117. <a href="https://doi.org/10.1016/j.molmed.2020.08.007">Link to article on publisher's site</a></p> | |
| dc.identifier.issn | 1471-4914 (Linking) | |
| dc.identifier.doi | 10.1016/j.molmed.2020.08.007 | |
| dc.identifier.pmid | 32988738 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/41590 | |
| dc.description.abstract | RNA therapeutics are finally taking their place as a main drug category alongside small molecules and proteins. Here, we follow the twists and turns on their road to success and highlight areas of ongoing research. | |
| dc.language.iso | en_US | |
| dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=32988738&dopt=Abstract">Link to Article in PubMed</a></p> | |
| dc.relation.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518117/ | |
| dc.subject | antisense | |
| dc.subject | aptamer | |
| dc.subject | miRNA | |
| dc.subject | oligonucleotide | |
| dc.subject | siRNA | |
| dc.subject | therapeutic | |
| dc.subject | Chemicals and Drugs | |
| dc.subject | Investigative Techniques | |
| dc.subject | Molecular Biology | |
| dc.subject | Nucleic Acids, Nucleotides, and Nucleosides | |
| dc.subject | Therapeutics | |
| dc.title | RNA Therapeutics Are Stepping Out of the Maze | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Trends in molecular medicine | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/oapubs/4379 | |
| dc.identifier.contextkey | 20053067 | |
| html.description.abstract | <p>RNA therapeutics are finally taking their place as a main drug category alongside small molecules and proteins. Here, we follow the twists and turns on their road to success and highlight areas of ongoing research.</p> | |
| dc.identifier.submissionpath | oapubs/4379 | |
| dc.contributor.department | Department of Medicine |
Files in this item
Name:
Publisher version